Deep phenotyping of skin tissue remodeling in patients with systemic…
Skin biopsies show that CAR-T cell therapy can reverse tissue scarring in systemic sclerosis, a major shift from thinking fibrosis is permanent.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
WISDOM randomized trial comparing risk-based versus annual breast…
Nearly 9 in 10 people prefer personalized breast cancer screening based on individual risk, showing strong public support for moving beyond one-size-fits-all approaches.
Promising but preliminarySCRUM-Japan MONSTAR3 hematology cohort
Japan launches its first nationwide multi-omics study of blood cancers, positioning doctors to match treatments to each patient's unique tumor biology.
Near-term implementable findingLongitudinal Plasma Proteomics Reveals an Immuno-thrombotic Signature…
A simple four-protein blood test predicts who will develop severe lung inflammation after cancer radiation, enabling preventive strategies before harm occurs.
Near-term implementable findingPersonalization of Neoadjuvant Immunotherapy in High-Risk Resectable…
Blood-based tumor DNA helps guide surgical decisions in melanoma, offering a non-invasive way to personalize care beyond standard approaches.